|
News for Healthier Living
UH Harrington Heart & Vascular Institute First Site in Ohio
to Provide More Accurate and Convenient PET MPI Cardiac Stress Test
University Hospitals Harrington Heart & Vascular Institute is the first site in the state of Ohio to clinically administer the FDA-approved Flyrcado(tm) (flurpiridaz F 18) injection to patients with known or suspected coronary artery disease.
June 13, 2025
June 13 2025June 12 2025June 11 2025June 10 2025June 9 2025June 8 2025June 7 2025June 6 2025June 5 2025June 4 2025June 3 2025June 2 2025June 1 2025May 31 2025
|
|
|
|
|